Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ERIS LIFESCIENCES vs ZYDUS LIFESCIENCES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ERIS LIFESCIENCES ZYDUS LIFESCIENCES ERIS LIFESCIENCES/
ZYDUS LIFESCIENCES
 
P/E (TTM) x 21.1 21.6 98.0% View Chart
P/BV x 4.4 2.6 169.8% View Chart
Dividend Yield % 1.0 0.6 169.6%  

Financials

 ERIS LIFESCIENCES   ZYDUS LIFESCIENCES
EQUITY SHARE DATA
    ERIS LIFESCIENCES
Mar-22
ZYDUS LIFESCIENCES
Mar-22
ERIS LIFESCIENCES/
ZYDUS LIFESCIENCES
5-Yr Chart
Click to enlarge
High Rs863674 128.1%   
Low Rs577331 174.2%   
Sales per share (Unadj.) Rs99.1149.1 66.5%  
Earnings per share (Unadj.) Rs29.922.7 131.4%  
Cash flow per share (Unadj.) Rs34.629.7 116.6%  
Dividends per share (Unadj.) Rs6.012.50 240.4%  
Avg Dividend yield %0.80.5 167.8%  
Book value per share (Unadj.) Rs140.2166.1 84.5%  
Shares outstanding (eoy) m135.931,023.74 13.3%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x7.33.4 215.6%   
Avg P/E ratio x24.122.1 109.1%  
P/CF ratio (eoy) x20.816.9 122.9%  
Price / Book Value ratio x5.13.0 169.7%  
Dividend payout %20.111.0 183.0%   
Avg Mkt Cap Rs m97,846514,277 19.0%   
No. of employees `000NANA-   
Total wages/salary Rs m2,52321,777 11.6%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m13,470152,652 8.8%  
Other income Rs m2612,354 11.1%   
Total revenues Rs m13,731155,006 8.9%   
Gross profit Rs m4,85034,427 14.1%  
Depreciation Rs m6477,130 9.1%   
Interest Rs m421,270 3.3%   
Profit before tax Rs m4,42228,381 15.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3645,117 7.1%   
Profit after tax Rs m4,05823,264 17.4%  
Gross profit margin %36.022.6 159.7%  
Effective tax rate %8.218.0 45.7%   
Net profit margin %30.115.2 197.7%  
BALANCE SHEET DATA
Current assets Rs m7,110122,614 5.8%   
Current liabilities Rs m2,83378,394 3.6%   
Net working cap to sales %31.729.0 109.6%  
Current ratio x2.51.6 160.4%  
Inventory Days Days15193 162.6%  
Debtors Days Days4480 54.6%  
Net fixed assets Rs m14,017144,382 9.7%   
Share capital Rs m1361,024 13.3%   
"Free" reserves Rs m18,928168,972 11.2%   
Net worth Rs m19,064169,996 11.2%   
Long term debt Rs m4503,621 12.4%   
Total assets Rs m21,127266,996 7.9%  
Interest coverage x105.823.3 453.2%   
Debt to equity ratio x00 110.8%  
Sales to assets ratio x0.60.6 111.5%   
Return on assets %19.49.2 211.2%  
Return on equity %21.313.7 155.5%  
Return on capital %22.917.1 134.0%  
Exports to sales %00-   
Imports to sales %0.814.3 5.8%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m11121,869 0.5%   
Fx inflow Rs m063,065 0.0%   
Fx outflow Rs m11121,869 0.5%   
Net fx Rs m-11141,196 -0.3%   
CASH FLOW
From Operations Rs m3,78321,041 18.0%  
From Investments Rs m-3,19611,544 -27.7%  
From Financial Activity Rs m-447-8,683 5.1%  
Net Cashflow Rs m14023,729 0.6%  

Share Holding

Indian Promoters % 52.7 75.0 70.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 25.4 16.2 156.9%  
FIIs % 15.5 2.5 617.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 47.3 25.0 189.0%  
Shareholders   46,746 370,396 12.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ERIS LIFESCIENCES With:   SUN PHARMA    DR. REDDYS LAB    CIPLA    LUPIN    AUROBINDO PHARMA    


More on ERIS LIFESCIENCES vs Cadila Healthcare

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ERIS LIFESCIENCES vs Cadila Healthcare Share Price Performance

Period ERIS LIFESCIENCES Cadila Healthcare S&P BSE HEALTHCARE
1-Day -0.46% 0.67% -0.34%
1-Month -8.08% 2.67% -2.09%
1-Year -12.39% 5.91% -6.69%
3-Year CAGR 4.96% 17.53% 17.24%
5-Year CAGR -4.77% 0.28% 9.09%

* Compound Annual Growth Rate

Here are more details on the ERIS LIFESCIENCES share price and the Cadila Healthcare share price.

Moving on to shareholding structures...

The promoters of ERIS LIFESCIENCES hold a 52.7% stake in the company. In case of Cadila Healthcare the stake stands at 75.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ERIS LIFESCIENCES and the shareholding pattern of Cadila Healthcare.

Finally, a word on dividends...

In the most recent financial year, ERIS LIFESCIENCES paid a dividend of Rs 6.0 per share. This amounted to a Dividend Payout ratio of 20.1%.

Cadila Healthcare paid Rs 2.5, and its dividend payout ratio stood at 11.0%.

You may visit here to review the dividend history of ERIS LIFESCIENCES, and the dividend history of Cadila Healthcare.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rebounds 400 Points from Day's Low | PSU Bank Stocks Rise Ahead of Union Budget 2023 | SBI Jumps 3% Sensex Today Rebounds 400 Points from Day's Low | PSU Bank Stocks Rise Ahead of Union Budget 2023 | SBI Jumps 3%(Closing)

After opening the day on a positive note, Indian share markets swung between gains and losses to trade on a volatile session throughout the day.